Food Advisory Panel To Address Dietary Supplement, Infant Formula Issues
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement and infant formula issues will be discussed at the next meeting of FDA's Food Advisory Committee, scheduled for Dec. 10-11
You may also be interested in...
“Metabolite” DSHEA Definition Incorporates Oral Ingestion
The definition of "metabolite" established by FDA's Food Advisory/Dietary Supplement Subcommittee meets DSHEA's statutory requirements by addressing human consumption, according to panelist Eric Brass, MD/PhD, Harbor-UCLA Center for Clinical Pharmacology
Infant Formula Growth Studies Advised For Certain Soy, Iron Sources By FAC
A growth study should be conducted when a soy protein stripped of isoflavones has been added to an infant formula to ensure its safety, Virginia Stallings, MD, Children's Hospital of Philadelphia, theorized
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC